RAPT Therapeutics, Inc. (RAPT) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-03-05

RAPT Therapeutics, Inc. (RAPT) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every RAPT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About RAPT Therapeutics, Inc. (RAPT)

SEC CIK	0001673772

Recent RAPT Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-03-03	Kozick Linda	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	Braunstein Scott	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	Lyons-Williams Lori	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	GRAY MARY ANN	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	Giordano Michael F	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	Dombkowski Ashley L.	Insider	J — Other acquisition / disposition	5.0K	—	—	SEC
2026-03-03	Young Rodney KB	CHIEF FINANCIAL OFFICER	J — Other acquisition / disposition	3.3K	—	—	SEC
2026-03-03	Brockstedt Dirk G.	CHIEF SCIENTIFIC OFFICER	J — Other acquisition / disposition	4.6K	—	—	SEC
2026-03-03	Wong Brian Russell	PRESIDENT AND CEO	J — Other acquisition / disposition	64.1K	—	—	SEC
2026-01-30	Dombkowski Ashley L.	Insider	A — Grant or award	5.0K	$0.00	—	SEC
2026-01-30	Lyons-Williams Lori	Insider	A — Grant or award	5.0K	$0.00	—	SEC
2026-01-30	Kozick Linda	Insider	A — Grant or award	5.0K	$0.00	—	SEC
2026-01-30	Braunstein Scott	Insider	A — Grant or award	5.0K	$0.00	—	SEC
2026-01-30	Giordano Michael F	Insider	A — Grant or award	5.0K	$0.00	—	SEC
2026-01-30	GRAY MARY ANN	Insider	A — Grant or award	5.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for RAPT Therapeutics, Inc. (RAPT). Updated in real time as new filings are submitted to the SEC.

Recent RAPT Form 8-K Material Events

2026-03-03 — Item 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01 · Acquisition · neutral [SEC]
RAPT Therapeutics' tender offer for acquisition by GlaxoSmithKline (GSK) expired on March 2, 2026, with approximately 93.36% of outstanding shares tendered at $58.00 per share. The Minimum Condition has been satisfied and Purchaser has accepted all validly tendered shares for pay

Recent Insider Filings

2026-03-05 — Lyons-Williams Lori (Insider)
2026-03-05 — GRAY MARY ANN (Insider)
2026-03-05 — Giordano Michael F (Insider)
2026-03-05 — Dombkowski Ashley L. (Insider)
2026-03-05 — Young Rodney KB (CHIEF FINANCIAL OFFICER)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RAPT insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

RAPT Insider Trading — FAQ

What is the latest insider trade for RAPT?: RAPT Therapeutics, Inc. (RAPT) had 0 insider filings in the last 90 days, with the most recent on 2026-03-05. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying RAPT stock?: 0 insider purchases of RAPT were filed in the last 90 days.
How many insiders are selling RAPT stock?: 0 insider sales of RAPT were filed in the last 90 days.
Where can I see RAPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every RAPT SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live RAPT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.